Trastuzumab Modulates the Protein Cargo of Extracellular Vesicles Released by ERBB2(+) Breast Cancer Cells

Cancers overexpressing the ERBB2 oncogene are aggressive and associated with a poor prognosis. Trastuzumab is an ERBB2 specific recombinant antibody employed for the treatment of these diseases since it blocks ERBB2 signaling causing growth arrest and survival inhibition. While the effects of Trastu...

Full description

Saved in:
Bibliographic Details
Published in:Membranes (Basel)
Main Authors: Marconi, Silvia, Santamaria, Sara, Bartolucci, Martina, Stigliani, Sara, Aiello, Cinzia, Gagliani, Maria Cristina, Bellese, Grazia, Petretto, Andrea, Cortese, Katia, Castagnola, Patrizio
Format: Artigo
Language:Inglês
Published: MDPI 2021
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8000509/
https://ncbi.nlm.nih.gov/pubmed/33809102
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/membranes11030199
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items